Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Division of Patient-Centered Development

Division of Patient-Centered Development

                        CDRH Patient Engagement Advisory Committee
          Patient Preference Information (PPI) in Medical Device Decision Making
          Clinical Outcome Assessments (COAs) in Medical Device Decision Making
          CDRH Patient and Caregiver Connection
          CDRH Patient Engagement
          Engaging Patients Is Part of CDRH Culture: Videos
          Best Practices for Communicating Cybersecurity Vulnerabilities to Patients Home
          About FDA
          FDA Organization
          Center for Devices and Radiological Health
          Division of Patient-Centered Development
          CDRH Patient Engagement Advisory CommitteeDivision of Patient-Centered Development CDRH Patient Engagement Advisory Committee
  
  	
    Share
    Post
    Linkedin

    Email
    PrintPatient Engagement Advisory Committee: Advancing Health Equity in Medical Devices - Virtual Event September 6, 2023
2023 Advisory Committee Meeting

On September 6, 2023, in a virtual meeting, the Patient Engagement Advisory Committee (the Committee) will meet to discuss and make recommendations on **Advancing Health Equity in Medical Devices.**

FDA CDRH is committed to working toward assuring that all patients have access to high-quality, safe and effective medical devices. This includes ensuring devices are designed to be safe and effective when used by various populations, are evaluated in the diverse populations for which they are intended, and that patients and consumers have the information they need to make decisions about their health, care, and quality of life. In addition, technology, including digital health technology, may help bridge gaps in health equity by extending access and bringing health care to patients at home, at work, and in their communities. The recommendations provided by the committee will address considerations for the FDA and industry on these topics.

The Committee will consider ways to advance access to devices that allow for care outside a hospital or clinical care setting, for example, in the home setting.  The Committee will also discuss considerations for improving reach and comprehension of FDA’s patient and caregiver communications, across diverse demographic groups.  Additionally, the Committee will discuss patient-focused considerations for when a device should be evaluated in diverse populations to support marketing authorization.

For details, see September 6, 2023: Patient Engagement Advisory Committee Meeting Announcement.

The Patient Engagement Advisory Committee (PEAC) is the first and only advisory committee whose members are all patients, caregivers, and representatives of patient organizations.

The FDA established the Committee to help assure that the needs and experiences of patients are included as part of the FDA’s deliberations on complex issues involving the regulation of medical devices and their use by patients.

This Committee brings patients, caregivers, patient organizations, and experts together for a broader discussion of important patient-related issues. Such discussions may help inform device innovation, development, evaluation, and access, and help the FDA meet its public health commitment to protect and promote public health.

For details on the Patient Engagement Advisory Committee’s charter and past meeting materials, see Advisory Committees – Patient Engagement Advisory Committee.

Committee Membership

The Committee is made up of a core of nine voting members plus one non-voting industry representative and one voting consumer representative. For specific meetings that need expertise beyond the core membership, the Committee can reach out to experts that participate on this and other advisory panels for the FDA and the National Institutes of Health.

For details on current committee members, see Roster of the Patient Engagement Advisory Committee.

For information about how to nominate yourself or another candidate to participate in the Committee, see Applying for Membership on FDA Advisory Committees.

**Discussion Topics**

The Committee may advise CDRH on topics such as:

Agency guidance and policies
	Design of clinical studies
	Real-world data
	Science of patient input
	Communication of device benefits and risks
	Digital health technologyExecutive Summaries from previous Committee meetings include:

2022: Augmented Reality and Virtual Reality Medical Devices
	2021: Medical Device Recalls: Patient-Focused Communications
	2020: Artificial Intelligence (AI) and Machine Learning (ML) in Medical Devices
	2019: Cybersecurity in Medical Devices
	2018: Patient-Generated Health Data
	2017: Patient Engagement in Medical Device Clinical TrialsActions taken by the FDA in response to feedback from the Committee meetings include:

2021
	Hosted the Virtual Public Meeting - Patient-Generated Health Data (PGHD) Throughout the Total Product Life Cycle of Medical Devices
		Published Artificial Intelligence/Machine Learning (AI/ML) action plan that includes a diversity plan to support regulatory science efforts in the identification and elimination of bias in AI/ML algorithms
		Posted Communicating Cybersecurity Vulnerabilities to Patients: Considerations for a Framework discussion guide
	2020
	Posted a video encouraging underrepresented populations to participate in medical device trials
		Announced the development of a video miniseries on cybersecurity that includes videos designed for patients
	2019
	Issued the draft guidance entitled “Patient Engagement in the Design and Conduct of Medical Device Clinical Investigations”
	2018
	Supported the principle of sharing data collected by medical devices to help protect and promote public health**Related information**: Meeting materials for the Patient Engagement Advisory Committee

Federal Register Notices

Federal Register: Patient Engagement Advisory Committee; Notice of Meeting
	Federal Register: Establishment of the Patient Engagement Advisory Committee
	Federal Register: Nominations for Industry Representative for PEAC
	Federal Register: Nominations for Consumer Representative for PEAC
	Federal Register: Nominations for Committee Members for PEAC
	October 4, 2016 - Requests for Nominations: Voting Members, Patient Engagement Advisory Committee

                                                                                  Content current as of:
      05/30/2023
              
              
Regulated Product(s)
		 Medical DevicesDivision of Patient-Centered Development

          
                        CDRH Patient Engagement Advisory Committee
          Patient Preference Information (PPI) in Medical Device Decision Making
          Clinical Outcome Assessments (COAs) in Medical Device Decision Making
          CDRH Patient and Caregiver Connection
          CDRH Patient Engagement
          Engaging Patients Is Part of CDRH Culture: Videos
          Best Practices for Communicating Cybersecurity Vulnerabilities to Patients
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop